BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 333629)

  • 1. [Advantages and technical conditions of the migration inhibition test [MIF] in agarose gel (author's transl)].
    Cabarcos A; Pérez-Miranda M; Uribarrena R; Pons F
    Sangre (Barc); 1977; 22(5):541-9. PubMed ID: 333629
    [No Abstract]   [Full Text] [Related]  

  • 2. [The mechanism of the in vitro migration inhibition test (author's transl)].
    Sabioncello A; Dekaris D
    Lijec Vjesn; 1978 Sep; 100(9):535-42. PubMed ID: 368478
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies of assay conditions for macrophage migration from an agarose droplet.
    Fahlbusch B; Dornberger G
    Acta Biol Med Ger; 1979; 38(10):1453-60. PubMed ID: 44954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An in vitro assay for uni-directional migration inhibition employing 51Cr-labelled macrophages.
    Noronha-Blob L; Huang SW
    Clin Exp Immunol; 1980 Jun; 40(3):627-32. PubMed ID: 6998620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Products of activated lymphocytes: leukocyte inhibitory factor (LIF) distinct from migration inhibitory factor (MIF).
    Rocklin RE
    J Immunol; 1974 Apr; 112(4):1461-6. PubMed ID: 4592603
    [No Abstract]   [Full Text] [Related]  

  • 6. [Macrophage inhibitory factor in pregnant women (author's transl)].
    Knobloch V; Jouja V; Svobodová M
    Cesk Gynekol; 1978 Mar; 43(1):11-4. PubMed ID: 346241
    [No Abstract]   [Full Text] [Related]  

  • 7. Guinea pig lymphocyte-derived macrophage aggregation factor: its separation from macrophage migration inhibitory factor.
    Postlethwaite AE; Kang AH
    J Immunol; 1976 Nov; 117(5 Pt 1):1651-5. PubMed ID: 794415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphokines in sensitized rats. I. Migration inhibitory factor(s) from specifically stimulated thymocytes in vitro.
    Bakker WW; Engelhart JJ; Mulder I; Hoedemaeker PJ
    Int Arch Allergy Appl Immunol; 1975; 49(4):491-503. PubMed ID: 1099009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of macrophage migration by plasma factor(s) from patients with neoplasms and normal individuals.
    Bice DE; Gruwell D; Salvaggio J
    J Reticuloendothel Soc; 1976 May; 19(5):281-9. PubMed ID: 775085
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of two lymphokines (macrophage migration inhibition, leukocyte adherence inhibition factors) and carcinoembryonic antigen, in colorectal cancer and colonic premalignant lesions.
    Shkolnik T; Livni E; Reshef R; Lachter J; Eidelman S
    Am J Gastroenterol; 1987 Dec; 82(12):1275-8. PubMed ID: 3318403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Production of leucocyte inhibitory factor (LIF) and macrophage inhibitory factor (MIF) by PHA-stimulated lymphocytes.
    Ruthlomnitzer ; Rabson AR; Koornhof HJ
    Clin Exp Immunol; 1975 Dec; 22(3):522-7. PubMed ID: 773578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The enhancement of MIF activity by inhibition of macrophage associated esterases.
    Remold HG
    J Immunol; 1974 Apr; 112(4):1571-7. PubMed ID: 4592606
    [No Abstract]   [Full Text] [Related]  

  • 13. Role of macrophage activation on the response to migration inhibitory factor (MIF).
    Leu RW; Woodson PD; Whitley SB
    J Reticuloendothel Soc; 1977 Oct; 22(4):329-40. PubMed ID: 336882
    [No Abstract]   [Full Text] [Related]  

  • 14. [Lymphokines, with special reference to skin reactive factor (SRF) (author's transl)].
    Aoki T
    Rinsho Byori; 1981 Dec; 29(12):1223-7. PubMed ID: 7040741
    [No Abstract]   [Full Text] [Related]  

  • 15. Characterization of macrophage migration inhibitory factor activity produced in vivo by a cell-mediated immune reaction in the guinea pig.
    Postlethywaite AE; Townes AS; Kang AH
    J Immunol; 1976 Nov; 117(5 Pt 1):1716-20. PubMed ID: 794416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Refractoriness to migration inhibitory factor of macrophages of LPS nonresponder mouse strains.
    Tagliabue A; McCoy JL; Herberman RB
    J Immunol; 1978 Oct; 121(4):1223-6. PubMed ID: 359704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Determination of macrophage migration inhibitory factor in the HEPES-buffered agarose medium. Modification of clausen's method].
    Nakagawa J; Okimoto Y; Era K; Ito K; Fukase M
    Ryumachi; 1974 Oct; 14(3):270-3. PubMed ID: 4375308
    [No Abstract]   [Full Text] [Related]  

  • 18. The activation of mononuclear phagocytes in vitro: immunologically mediated enhancement.
    Adams DO; Biesecker JL; Koss LG
    J Reticuloendothel Soc; 1973 Dec; 14(6):550-70. PubMed ID: 4204505
    [No Abstract]   [Full Text] [Related]  

  • 19. [Experimental studies on tuberculin hypersensitivity--immunological significance of leucocyte migration inhibitory factor (LIF) and macrophage migration inhibitory factor (MIF) (author's transl)].
    Matsui Y; Oshima S
    Kekkaku; 1979 Jun; 54(6):331-44. PubMed ID: 388018
    [No Abstract]   [Full Text] [Related]  

  • 20. [Influence of the irritant used to provoke the peritoneal exudate used in the macrophage migration inhibition test (author's transl)].
    Fray A; Lorinet AM; Halpern B
    Ann Immunol (Paris); 1979; 130C(3):367-72. PubMed ID: 475342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.